Adult Dosing

Allergic conjunctivitis

• Instill 1 gtt in the eye(s) qd

Pediatric Dosing

• Safety and effectiveness in pediatric patients <2 yrs of age have not been established

Allergic conjunctivitis

Children 2 yrs

• Instill 1 gtt in the eye(s) qd

[Outline]

• Adult Dosing
• Pediatric Dosing

• Prevention of itching associated with allergic conjunctivitis

• Hypersensitivity to any of the ingredients of the product

• N/A

Renal Dose Adjustment

• Renal impairment: Dose adjustments not defined

Hepatic Dose Adjustment

• Hepatic adjustment: Dose adjustments not defined

See Supplemental Patient Information

• Recommended for topical ophthalmic use only
• Avoid contaminating the applicator tip with material from the eye, fingers, surrounding areas or other source
• Do not wear a contact lens if the eye is red; do not use this drug to treat contact lens-related irritation
• Advise patients to avoid using contact lenses during treatment period

Supplemental Patient Information

• Advise patients not to touch dropper tip to any surface, as this may contaminate the contents
• Instruct patients wearing soft contact lenses to remove them prior to administration of the drug and to wait at least 10 minutes after instillation

Pregnancy Category:B

Breastfeeding: Safety unknown. Manufacturer advises caution.

• CNS: Headache
• EENT: Nasopharyngitis, ocular irritation, ocular burning and/or stinging upon instillation, eye redness, eye pruritus
• MISC: Influenza

• Histamine H1 antagonist; selectively antagonizes histamine H1 receptors and inhibits the release of histamine from mast cells; also exhibits decreased chemotaxis and inhibition of eosinophil activation
• Metabolized in liver to the active carboxylic acid metabolite
• Excreted unchanged in urine (based on oral administration data)
• Half-life: 2 hrs (carboxylic acid metabolite)

US Trade Name(s)

• Lastacaft

US Availability

Lastacaft

• OPTH SOLN: 0.25%

Canadian Trade Name(s)

• N/A

Canadian Availability

• N/A

UK Trade Name(s)

• N/A

UK Availability

• N/A

Australian Trade Name(s)

• N/A

Australian Availability

• N/A

[Outline]

Ophthalmic

Ophthalmic Antihistamines

Selective Histamine H1 Antagonists

Allergy & Immunology

Ophthalmic Antihistamines

Selective Histamine H1 Antagonists

Pricing data from www.DrugStore.com in U.S.A.

• Lastacaft 0.25 % SOLN [Bottle] (ALLERGAN)
  3 % = $112.99
  9 % = $319.98

Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.